LAB B logo

Genomma Lab Internacional, S.A.B. de C.V. Stock Price

BMV:LAB B Community·Mex$14.3b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 16 Fair Values set on narratives written by author

LAB B Share Price Performance

Mex$14.69
-7.33 (-33.29%)
Mex$30.00
Fair Value
Mex$14.69
-7.33 (-33.29%)
51.0% undervalued intrinsic discount
Mex$30.00
Fair Value
Price Mex$14.69
AnalystHighTarget Mex$30.00
AnalystLowTarget Mex$18.00
AnalystConsensusTarget Mex$24.40

LAB B Community Narratives

·
Fair Value Mex$30 51.0% undervalued intrinsic discount

Productivity Savings And Channel Expansion Will Support A Stronger Long Term Earnings Profile

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value Mex$18 18.4% undervalued intrinsic discount

Seasonal Volatility And Cost Cuts Will Test Margin Ambitions Yet Support A Cautious Upside View

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value Mex$24.4 39.8% undervalued intrinsic discount

Productivity Program And E Commerce Expansion Will Drive Long Term Market Share Gains

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Mex$18
18.4% undervalued intrinsic discount
Revenue
6.59% p.a.
Profit Margin
12.87%
Future PE
9.62x
Price in 2029
Mex$26.86
LAB B logo
Genomma Lab Internacional. de

Productivity Savings And Channel Expansion Will Support A Stronger Long Term Earnings Profile

Catalysts About Genomma Lab Internacional. de Genomma Lab Internacional.Read more

View narrative
Mex$30
51.0% undervalued intrinsic discount
Revenue
8.7% p.a.
Profit Margin
14.62%
Future PE
12.93x
Price in 2029
Mex$44.65

Trending Discussion

No trending discussion available.

Updated Narratives

LAB B logo

LAB B: Higher Revenue And Margin Assumptions Will Support Future Upside

Fair Value: Mex$18 18.4% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
LAB B logo

LAB B: Revised Profit Outlook Will Support Stronger Future Repricing

Fair Value: Mex$24.4 39.8% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
LAB B logo

Productivity Savings And Channel Expansion Will Support A Stronger Long Term Earnings Profile

Fair Value: Mex$30 51.0% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value with adequate balance sheet.

1 Risk
2 Rewards

Genomma Lab Internacional, S.A.B. de C.V. Key Details

Mex$17.0b

Revenue

Mex$6.3b

Cost of Revenue

Mex$10.8b

Gross Profit

Mex$9.2b

Other Expenses

Mex$1.6b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
1.67
63.25%
9.56%
66.0%
View Full Analysis

About LAB B

Founded
1996
Employees
1643
CEO
Juan Marco Sparvieri
WebsiteView website
www.genommalab.com

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Recent LAB B News & Updates

Narrative Update Jul 16

LAB B: Higher Revenue And Margin Assumptions Will Support Future Upside

The analyst price target for Genomma Lab Internacional has been revised from MX$20.00 to MX$18.00, with analysts attributing the change to updated assumptions for revenue growth, profit margins, and a lower future P/E multiple. What's in the News Analysts revised their price target for Genomma Lab Internacional from MX$20.00 to MX$18.00, citing updated assumptions for revenue growth, profit margins, and a lower future P/E multiple.

Recent updates

No updates

Genomma Lab Internacional, S.A.B. de C.V. Competitors